Pular para o conteúdo principal
Ranking Invest

AXNX - Axonics, Inc.

Segmento: HealthcareAxonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Análise Ranking Invest

Valuation estimado
$ 535.63 Mi
Último Balanço Atualizado: 3T2024

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 664.49 Mi

Dívida Líquida

-$ 206.94 Mi

L4T

-$ 5.66 Mi

MM4T

-2.23%

Indicadores Básicos

ROE

-0.85%

Índices de Previsibilidade

Receita Líquida

D0.14

Lucro

F5.36

Margem

E1.26

Índices de Tendência

Receita Líquida

B9.72

Lucro

A8.26

Margem

A9.56

Índices de Endividamento

DIV/PAT

-0.31

DIV/L4T

36.56

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.